Welcome to Palatin's Investor Relations Information Site. We are pleased to provide you with information regarding Palatin Technologies' financial highlights. For your convenience, we provide a library of press releases, events and webcasts, as well as prefiltered links to the EDGAR database.          Sign up here to receive Palatin Technologies financial information by e-mail.     Palatin at-a-Glance:   Palatin Technologies, Inc. (AMEX:PTN) is a biopharmaceutical company dedicated to the development of peptide, peptide mimetic and small molecule agonist compounds with a focus on melanocortin and natriuretic peptide receptor systems. Palatin is developing products targeting melanocortin and natriuretic receptors in the cardiovascular field, including acute hospital care products for congestive heart failure, hard-to-control hypertension and organ protection during cardiac surgery, and products for sexual dysfunction, obesity and related metabolic syndrome.

Latest News:   Nov-17-2008 Palatin Technologies, Inc. Reports Fiscal Year 2009 First Quarter Results; Teleconference and Webcast to be held on November 17, 2008   Nov-13-2008 Palatin Technologies To Report Fiscal Year 2009 First Quarter Results; Conference Call And Webcast On November 17, 2008   Sep-30-2008 Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2008 Results; Teleconference and Webcast to be held on September 30, 2008		Financial Snapshot:   (as of 3/31/08)   AMEX symbol: PTN Shares outstanding:      Common: 85 million    Fully diluted: 100 million 52-wk price range: $0.19 - $2.09 Market cap: $24 million Employees: 45 Headquarters: Cranbury, NJ Fiscal year end: June 30th CEO: Dr. Carl Spana

Portions of this website may contain forward-looking statements concerning the future business, operating results and/or financial condition of Palatin Technologies, Inc. as defined by the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s current expectations and are subject to a number of uncertainties that could cause actual performance and results to differ materially from those anticipated by such forward-looking statements. For more information about these risks, please see the documents that the Company files from time to time with the Securities and Exchange Commission. Any forward-looking statements on this website are based on current expectations, and Palatin Technologies assumes no obligation to update them.